We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAFAU
676
LaFayette Acquisition Corp Unit
LAFAU
$375K 0.03%
+37,399
New +$376K
CB icon
677
Chubb
CB
$134B
$375K 0.03%
+1,200
New +$351K
MMM icon
678
3M
MMM
$93.9B
$374K 0.03%
2,338
+809
+53% +$132K
PJT icon
679
PJT Partners
PJT
$4.33B
$373K 0.03%
2,233
+576
+35% +$98.5K
PHM icon
680
Pultegroup
PHM
$24.8B
$373K 0.03%
+3,180
New +$390K
ABCL icon
681
AbCellera Biologics
ABCL
$2.85B
$373K 0.03%
+109,000
New +$487K
ALNY icon
682
Alnylam Pharmaceuticals
ALNY
$29B
$369K 0.03%
+928
New +$411K
BNY
683
Bank of New York Mellon
BNY
$108B
$368K 0.03%
3,166
+317
+11% +$35.1K
ATKR icon
684
Atkore
ATKR
$3.17B
$367K 0.03%
5,800
-975
-14% -$63.6K
PD icon
685
PagerDuty
PD
$916M
$366K 0.03%
27,924
+11,959
+75% +$174K
SEB icon
686
Seaboard Corp
SEB
$4.06B
$364K 0.03%
82
+10
+14% +$39.5K
TNL icon
687
Travel + Leisure Co
TNL
$4.5B
$363K 0.03%
5,152
-9,254
-64% -$606K
APA icon
688
APA Corp
APA
$14.4B
$363K 0.03%
+14,849
New +$359K
EA
689
CALL
DELISTED
Electronic Arts
EA
$363K 0.03%
+390
New +$78.7K
FERG icon
690
Ferguson
FERG
$51.2B
$362K 0.03%
+1,624
New +$388K
ARES icon
691
Ares Management
ARES
$31B
$360K 0.03%
+2,230
New +$347K
WSM icon
692
Williams-Sonoma
WSM
$29.5B
$360K 0.03%
+2,016
New +$378K
HAL icon
693
Halliburton
HAL
$28B
$360K 0.03%
+12,728
New +$336K
CMDB
694
Costamare Bulkers Holdings
CMDB
$424M
$360K 0.03%
+23,334
New +$338K
VNET
695
VNET Group
VNET
$2.13B
$360K 0.03%
42,500
-13,600
-24% -$126K
ACWV icon
696
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$359K 0.03%
+3,020
New +$361K
BDX icon
697
Becton Dickinson
BDX
$48.9B
$357K 0.03%
+1,838
New +$350K
WAB icon
698
Wabtec
WAB
$49.7B
$356K 0.03%
+1,669
New +$343K
SB icon
699
Safe Bulkers
SB
$764M
$356K 0.03%
73,874
+9,081
+14% +$43.1K
BRO icon
700
Brown & Brown
BRO
$24B
$356K 0.03%
+4,465
New +$373K

Similar funds

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.